The MAPK pathway across different malignancies: A new perspective von Burotto, Mauricio, Chiou, Victoria L., Lee, Jung‐Min, Kohn, Elise C.

Volltext

Pseudoprogression and Immune-Related Response in Solid Tumors von Chiou, Victoria L, Burotto, Mauricio

Volltext

Gefitinib and Erlotinib in Metastatic Non‐Small Cell Lung Cancer: A Meta‐Analysis of Toxicity and Efficacy of Randomized Clinical Trials von Burotto, Mauricio, Manasanch, Elisabet E., Wilkerson, Julia, Fojo, Tito

Volltext

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial von Albiges, Laurence, Tannir, Nizar M, Burotto, Mauricio, McDermott, David, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, Powles, Thomas, Donskov, Frede, George, Saby, Kollmannsberger, Christian K, Gurney, Howard, Grimm, Marc-Oliver, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Choueiri, Toni K, Saggi, Shruti Shally, McHenry, M Brent, Motzer, Robert J

Volltext

Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins von Poruchynsky, Marianne S., Komlodi-Pasztor, Edina, Trostel, Shana, Wilkerson, Julia, Regairaz, Marie, Pommier, Yves, Zhang, Xu, Maity, Tapan Kumar, Robey, Robert, Burotto, Mauricio, Sackett, Dan, Guha, Udayan, Fojo, Antonio Tito

Volltext

MAP4K4 and cancer: ready for the main stage? von González-Montero, Jaime, Rojas, Carlos I, Burotto, Mauricio

Volltext

Adjuvant therapy for renal cell carcinoma, finally a new standard? von Renner, Alex, Rojas, Carlos, Walton-Diaz, Annerleim, Burotto, Mauricio

Volltext

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards? von Renner, Alex, Burotto, Mauricio, Valdes, Jose Miguel, Roman, Juan Carlos, Walton-Diaz, Annerleim

Volltext

Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature von Salinas, Carlos, Renner, Alex, Rojas, Carlos, Samtani, Suraj, Burotto, Mauricio

Volltext

Continuing a cancer treatment despite tumor growth may be valuable: sunitinib in renal cell carcinoma as example von Burotto, Mauricio, Wilkerson, Julia, Stein, Wilfred, Motzer, Robert, Bates, Susan, Fojo, Tito

Volltext

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma? von Renner, Alex, Samtani, Suraj, Marín, Arnaldo, Burotto, Mauricio

Volltext

Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial von Fizazi, Karim, Retz, Margitta, Petrylak, Daniel P, Goh, Jeffrey C, Perez-Gracia, Jose, Lacombe, Louis, Zschäbitz, Stefanie, Burotto, Mauricio, Mahammedi, Hakim, Gravis, Gwenaelle, Bastos, Diogo Assed, McCune, Steven L, Vázquez Limón, Juan Carlos, Kwan, Edmond M, Castellano, Daniel, Fléchon, Aude, Saad, Fred, Grimm, Marc-Oliver, Shaffer, David R, Armstrong, Andrew J, Bhagavatheeswaran, Prabhu, Amin, Neha P, Ünsal-Kaçmaz, Keziban, Wang, Xuya, Li, Jun, Loehr, Andrea, Pachynski, Russell K

Volltext

The Strength of Association Between Surrogate End Points and Survival in Oncology: A Systematic Review of Trial-Level Meta-analyses von Prasad, Vinay, Kim, Chul, Burotto, Mauricio, Vandross, Andrae

Volltext

Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status von Blagoev, Krastan B, Wilkerson, Julia, Burotto, Mauricio, Kim, Chul, Espinal-Domínguez, Edward, García-Alfonso, Pilar, Alimchandani, Meghna, Miettinen, Markku, Blanco-Codesido, Montserrat, Fojo, Tito

Volltext

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden von Schenker, Michael, Burotto, Mauricio, Richardet, Martin, Ciuleanu, Tudor-Eliade, Gonçalves, Anthony, Steeghs, Neeltje, Schoffski, Patrick, Ascierto, Paolo A, Maio, Michele, Lugowska, Iwona, Lupinacci, Lorena, Leary, Alexandra, Delord, Jean-Pierre, Grasselli, Julieta, Tan, David S P, Friedmann, Jennifer, Vuky, Jacqueline, Tschaika, Marina, Konduru, Somasekhar, Vemula, Sai Vikram, Slepetis, Ruta, Kollia, Georgia, Pacius, Misena, Duong, Quyen, Huang, Ning, Doshi, Parul, Baden, Jonathan, Di Nicola, Massimo

Volltext

MRI and Targeted Biopsy Essential Tools for an Accurate Diagnosis and Treatment Decision Making in Prostate Cancer von Samtani, Suraj, Burotto, Mauricio, Roman, Juan Carlos, Cortes-Herrera, Daniela, Walton-Diaz, Annerleim

Volltext

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer von Barrientos, Rodrigo, Samtani, Suraj, Frelinghuysen, Michael, Sotomayor, Camilo, Gormaz, Juan Guillermo, Burotto, Mauricio

Volltext

Current Landscape of Immunotherapy Trials Involving the Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Axis in Intrathoracic Tumors von Kareff, Samuel A., Samtani, Suraj, Burotto, Mauricio, Prasad, Vinay, Kim, Chul

Volltext

PPARγ in head and neck cancer prevention von Burotto, Mauricio, Szabo, Eva

Volltext

Immune Checkpoint Inhibitor Dosing: Can We Go Lower Without Compromising Clinical Efficacy? von Renner, Alex, Burotto, Mauricio, Rojas, Carlos

Volltext